MEXBRAIN is a French biotechnology startup founded in 2017, which is dedicated to developing therapeutic dialysis devices for metal extraction. The company's slogan "Therapeutic dialysis devices for metal extraction" encapsulates its core mission. MexBrain's innovative approach involves the creation of medical devices capable of extracting specific metals rapidly and in a controlled manner. They have engineered an ultrachelating platform using fluids to extract metals linked to dialysis systems. Notably, these devices are tailored for targeted metals with adjustable extraction capacity, with the key advantage being that no drugs or compounds are directly circulated into the body, thus mitigating potential side effects. MexBrain recently received Non Equity Assistance investment on 31 August 2023, with WorldUpstart being the contributing investor. This investment signifies the potential for MexBrain's groundbreaking technology in the field of metal extraction and its application in dialysis, marking it as a startup to keep a close eye on in the biotech industry.
No recent news or press coverage available for MEXBRAIN.